Polygenic Contributions to Chronic Overlapping Pain Conditions in a Large Electronic Health Record Sample
The Journal of Pain · 2023
DOI: 10.1016/j.jpain.2023.01.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pain, 2023. Verfasst von Lori Schirle und 4 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University School of Nursing, Nashville, Tennessee. Electronic address: lori.schirle@vanderbilt.edu. Hauptthemen laut MEDLINE: Chronic Pain. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDA NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Chronic overlapping pain conditions (COPCs) are believed to share common etiological mechanisms involving central sensitization. Genetic and environmental factors putatively combine to influence susceptibility to central sensitization and COPCs. This study employed a genome-wide polygenic risk score approach to evaluate genetic influences on 8 common COPCs. COPCs were identified by International Classification of Disease codes in Vanderbilt's deidentified clinical biorepository (BioVU), with each COPC condition empirically weighted for the level of central sensitization based on prior work. A centralized pain score (CPS) was calculated for 55,340 individuals by summing the weighted number of COPCs. Overall, 12,502 individuals (22.6%) were diagnosed with at least 1 COPC, with females exhibiting nearly twice the mean CPS as males. To assess the genetic influence on centralized pain in COPCs, 6 pain polygenic risk scores (PRSs) were developed using UK Biobank data to predict 6 pain criteria (no pain, neck/shoulder, abdomen, hip, knee, low back pain). These PRSs were then deployed in the BioVU cohort to test for association with CPS. In regression models adjusted for age, sex, and BMI, all pain PRSs except hip pain were significantly associated with CPS. Our findings support a shared polygenic influence across COPCs potentially involving central sensitization mechanisms. PERSPECTIVE: This study used a polygenic risk score approach to investigate genetic influences on chronic overlapping pain conditions. Significant findings in this study provide evidence supporting previous hypotheses that a shared polygenic influence involving central sensitization may underly chronic overlapping pain conditions and can guide future biomarker and risk assessment research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vanderbilt University School of Nursing, Nashville, Tennessee. Electronic address: lori.schirle@vanderbilt.edu.
- Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Genetics Institute, Nashville, Tennessee.
- Vanderbilt Genetics Institute, Nashville, Tennessee.
- Vanderbilt Genetics Institute, Nashville, Tennessee; Department of Medicine, Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
- Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Förderung
- NHLBI NIH HHS
- NIDA NIH HHS
- NIGMS NIH HHS
- NIA NIH HHS
- NIDDK NIH HHS
- NCATS NIH HHS
- NHGRI NIH HHS
- NIMH NIH HHS
Zitieren
APA
Schirle, L., Samuels, D. C., Faucon, A., Cox, N. J., & Bruehl, S. (2023). Polygenic Contributions to Chronic Overlapping Pain Conditions in a Large Electronic Health Record Sample. The Journal of Pain. https://doi.org/10.1016/j.jpain.2023.01.018
Vancouver
Schirle L, Samuels DC, Faucon A, Cox NJ, Bruehl S. Polygenic Contributions to Chronic Overlapping Pain Conditions in a Large Electronic Health Record Sample. The Journal of Pain. 2023. doi:10.1016/j.jpain.2023.01.018
BibTeX
@article{Schirle2023,
author = {Schirle, Lori and Samuels, David C and Faucon, Annika and Cox, Nancy J and Bruehl, Stephen},
title = {Polygenic Contributions to Chronic Overlapping Pain Conditions in a Large Electronic Health Record Sample},
journal = {The Journal of Pain},
year = {2023},
doi = {10.1016/j.jpain.2023.01.018}
}
EUVIMED